S. Dimicoli

发表

[Very late malignant complications of Hodgkin lymphoma].

T. Molina, V. Gounant, B. Rio, 2011, La Revue de medecine interne.

Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study

P. Cony-Makhoul, P. Fenaux, T. Cluzeau, 2021, British journal of haematology.

Vinblastine for elderly and frail patients with Hodgkin lymphoma

N. Milpied, M. Dilhuydy, A. Lascaux, 2020, Leukemia & lymphoma.

Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add‐on study from the Groupe Francophone des Myelodysplasies

P. Cony-Makhoul, S. Chevret, E. Wattel, 2018, British journal of haematology.

Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate‐1 risk myelodysplastic syndrome

Z. Estrov, H. Kantarjian, G. Garcia-Manero, 2012, American journal of hematology.

Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies

J. Soria, A. Faussat, R. Tang, 2012, Cancer medicine.

Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol.

A. Vekhoff, O. Legrand, P. Hirsch, 2011, Leukemia research.

[Granulocyte sarcoma of the pancreas without extra-pancreatic location].

P. Feugier, E. Labouyrie, P. Lederlin, 2002, Presse medicale.

Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome

P. Feugier, F. Barbé, D. Bensoussan, 2003, Bone Marrow Transplantation.

Tumour lysis syndrome and acute kidney injury in high‐risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco‐Hématologique

P. Moreau, C. Récher, É. Azoulay, 2013, British journal of haematology.

Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells

D. Neuberg, B. Ebert, R. Chen, 2013, Leukemia.

Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes

R. Chen, G. Garcia-Manero, C. Dinardo, 2013, PloS one.

Toll-like receptor alterations in myelodysplastic syndrome

D. Neuberg, B. Ebert, R. Bejar, 2013, Leukemia.

Daclizumab, an efficient treatment for steroid‐refractory acute graft‐versus‐host disease

P. Feugier, P. Bordigoni, A. Salmon, 2006, British journal of haematology.

Immune reconstitution inflammatory syndrome following allo-SCT in a patient with Dipodascus capitatus spondylodiscitis

M. Bougnoux, F. Lanternier, S. Lapusan, 2011, Bone Marrow Transplantation.